Charming Competitors
| MCTA Stock | 29.36 0.00 0.00% |
Charming Medical vs Annexon Correlation
Very weak diversification
The correlation between Charming Medical Limited and ANNX is 0.47 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Charming Medical Limited and ANNX in the same portfolio, assuming nothing else is changed.
Moving against Charming Stock
The current year's Return On Tangible Assets is expected to grow to 0.21. The current year's Return On Capital Employed is expected to grow to 3.22. At present, Charming Medical's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Return On Tangible Assets is expected to grow to 0.21, whereas Total Assets are forecasted to decline to about 4.4 M.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Charming Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Charming Medical Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Charming Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Charming and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Charming Medical does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Charming Stock performing well and Charming Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Charming Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AGL | 5.06 | (0.80) | 0.00 | (0.17) | 0.00 | 10.00 | 30.19 | |||
| TCMD | 1.78 | 0.13 | 0.07 | 0.21 | 1.65 | 4.48 | 12.91 | |||
| CCRN | 2.45 | (0.68) | 0.00 | (0.55) | 0.00 | 5.51 | 24.90 | |||
| RXST | 3.05 | (0.11) | (0.01) | 0.03 | 3.53 | 7.97 | 23.38 | |||
| DCTH | 1.96 | 0.13 | 0.07 | 0.17 | 2.08 | 4.81 | 17.24 | |||
| SLP | 2.26 | (0.38) | 0.00 | (0.28) | 0.00 | 5.08 | 22.31 | |||
| EHAB | 1.65 | 0.46 | 0.21 | 1.32 | 1.50 | 4.81 | 11.79 | |||
| TOI | 4.19 | (0.63) | 0.00 | (0.26) | 0.00 | 6.53 | 42.16 | |||
| NAKA | 5.06 | (1.66) | 0.00 | (0.42) | 0.00 | 11.43 | 37.72 | |||
| ANNX | 4.05 | 1.07 | 0.26 | 5.13 | 3.32 | 11.30 | 35.10 |
Cross Equities Net Income Analysis
Compare Charming Medical and related stocks such as agilon health, Tactile Systems Tech, and Cross Country Healthcare Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AGL | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (60.1 M) | (406.5 M) | (106.6 M) | (262.6 M) | (260.2 M) | (234.1 M) | (245.8 M) |
| RXST | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 27.6 M | (48.7 M) | (66.8 M) | (48.6 M) | (27.5 M) | (24.7 M) | (23.5 M) |
| DCTH | (2 M) | (30.9 M) | (51.9 M) | (30.3 M) | (17.4 M) | (14.7 M) | (18 M) | (45.1 M) | (19.2 M) | (8.9 M) | (24.2 M) | (25.6 M) | (36.5 M) | (47.7 M) | (26.4 M) | (23.7 M) | (24.9 M) |
| SLP | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 5.8 M | 8.9 M | 8.6 M | 9.3 M | 9.8 M | 12.5 M | 10 M | 10 M | (64.7 M) | (58.2 M) | (55.3 M) |
| EHAB | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 75 M | 111.1 M | (40.4 M) | (80.5 M) | (156.2 M) | (140.6 M) | (133.6 M) |
| TOI | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | (4 M) | (14.3 M) | (10.9 M) | 152 K | (83.1 M) | (64.7 M) | (58.2 M) | (55.3 M) |
| NAKA | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | (2.5 M) | (1.6 M) | (3.6 M) | (3.3 M) | (3.1 M) |
| ANNX | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.3 M) | (37.2 M) | (62.7 M) | (127.8 M) | (138.3 M) | (134.2 M) | (138.2 M) | (124.4 M) | (130.6 M) |
Charming Medical and related stocks such as agilon health, Tactile Systems Tech, and Cross Country Healthcare Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Charming Medical financial statement analysis. It represents the amount of money remaining after all of Charming Medical Limited operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Charming Medical Competitive Analysis
The better you understand Charming Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Charming Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Charming Medical's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Charming Medical Competition Performance Charts
Five steps to successful analysis of Charming Medical Competition
Charming Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Charming Medical in relation to its competition. Charming Medical's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Charming Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Charming Medical's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Charming Medical, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Charming Medical position
In addition to having Charming Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Blend Funds Thematic Idea Now
Large Blend Funds
Fund or Etfs that invest in stocks of large organizations that have characteristics of both growth and value companies. The Large Blend Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Blend Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Charming Medical Correlation with its peers. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Medical Care Facilities space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Charming Medical. Expected growth trajectory for Charming significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Charming Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Charming Medical is measured differently than its book value, which is the value of Charming that is recorded on the company's balance sheet. Investors also form their own opinion of Charming Medical's value that differs from its market value or its book value, called intrinsic value, which is Charming Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Charming Medical's market value can be influenced by many factors that don't directly affect Charming Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Charming Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Charming Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Charming Medical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.